S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q3 2024

Perceptive Advisors

Period: Q3 2024 Β· Filed: 2024-11-14
View on SEC EDGAR β†—
AUM
$4.73B
Total portfolio value
Positions
108
Reported securities
Top Holding
ACLX
6.9% $324.7M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ACLXARCELLX INC$324.7M6.87%$83.51β€”
6.9%
NUVLNUVALENT INC$304.8M6.45%$102.30$123.73+20.9%
6.5%
FOLDAMICUS THERAPEUTICS INC$299.6M6.34%β€”β€”
6.3%
IOVAIOVANCE BIOTHERAPEUTICS INC$249.9M5.29%$9.39$4.31-54.1%
5.3%
PCVXVAXCYTE INC$231.7M4.90%$114.27$58.39-48.9%
4.9%
RYTMRHYTHM PHARMACEUTICALS INC$186.5M3.95%$52.39$114.17+117.9%
4.0%
VRNAVERONA PHARMA PLC$181.7M3.84%β€”β€”
3.8%
SLNOSOLENO THERAPEUTICS INC$161.8M3.42%$50.49β€”
3.4%
ITCIINTRA-CELLULAR THERAPIES INC$118.7M2.51%β€”β€”
2.5%
APGEAPOGEE THERAPEUTICS INC$118.4M2.50%$58.74$132.91+126.3%
2.5%
VKTXVIKING THERAPEUTICS INC$107.6M2.28%$63.31$37.44-40.9%
2.3%
CNTACENTESSA PHARMACEUTICALS PLC$100.5M2.13%$15.99$40.50+153.3%
2.1%
IMTXIMMATICS N.V$92.3M1.95%$11.41$9.95-12.8%
1.9%
EOLSEVOLUS INC$86.8M1.84%$16.20$6.90-57.4%
1.8%
SYRESPYRE THERAPEUTICS INC$84.5M1.79%$29.41$86.63+194.6%
1.8%
AORTARTIVION INC$74.4M1.57%$26.62$23.97-9.9%
1.6%
BHVNBIOHAVEN LTD$74.2M1.57%$49.97$15.96-68.1%
1.6%
ATXSASTRIA THERAPEUTICS INC$71.4M1.51%β€”β€”
1.5%
AXSMAXSOME THERAPEUTICS INC$70.3M1.49%$89.87$244.31+171.8%
1.5%
APLTAPPLIED THERAPEUTICS INC$68.0M1.44%β€”β€”
1.4%
CRGXCARGO THERAPEUTICS INC$68.0M1.44%β€”β€”
1.4%
IMVTIMMUNOVANT INC$67.8M1.43%$28.51$38.79+36.1%
1.4%
PRAXPRAXIS PRECISION MEDICINES I$67.0M1.42%$57.54$318.52+453.6%
1.4%
ARGXARGENX SE$64.4M1.36%$542.08$939.68+73.3%
1.4%
VRDNVIRIDIAN THERAPEUTICS INC$64.0M1.35%$22.75$19.40-14.7%
1.4%
EWTXEDGEWISE THERAPEUTICS INC$62.2M1.32%$26.69$39.56+48.2%
1.3%
PTGXPROTAGONIST THERAPEUTICS INC$61.9M1.31%$45.00$131.62+192.5%
1.3%
MGTXMEIRAGTX HLDGS PLC$52.4M1.11%$4.17$13.92+233.8%
1.1%
ALDXALDEYRA THERAPEUTICS INC$50.0M1.06%$5.39$2.27-57.9%
1.1%
AKROAKERO THERAPEUTICS INC$49.2M1.04%β€”β€”
1.0%

Quarter-on-Quarter Activity

Q3 2024 vs. Q2 2024

New Positions (8)

TickerIssuerNotional
PODDINSULET CORP$33.1M
ORKAORUKA THERAPEUTICS INC$30.3M
DYNDYNE THERAPEUTICS INC$25.8M
ADGMADAGIO MED HLDGS INC$25.3M
TILINSTIL BIO INC$23.3M
ZBIOZENAS BIOPHARMA INC$19.4M
XNCRXENCOR INC$10.6M
ROIVROIVANT SCIENCES LTD$9.8M

Exited Positions (8)

TickerIssuerNotional
CERECEREVEL THERAPEUTICS HLDNG I$441.4M
MDGLMADRIGAL PHARMACEUTICALS INC$74.1M
ABIOARCA BIOPHARMA INC$59.4M
BBIOBRIDGEBIO PHARMA INC$30.8M
CGEMCULLINAN THERAPEUTICS INC$13.1M
TEMTEMPUS AI INC$9.6M
ENGNENGENE HOLDINGS INC$7.5M
SPRYARS PHARMACEUTICALS INC$7.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
XBIPUTSPDR SER TR$37.4M+1664.8%
IMVTIMMUNOVANT INC$62.5M+1089.4%+36.1%
ARGXARGENX SE$57.7M+661.8%+73.3%
VRNACALLVERONA PHARMA PLC$146.5M+159.5%
VKTXVIKING THERAPEUTICS INC$69.4M+135.7%-40.9%
OBIOORCHESTRA BIOMED HLDGS INC$2.9M+80.4%
VRDNVIRIDIAN THERAPEUTICS INC$42.8M+72.4%-14.7%
AXSMAXSOME THERAPEUTICS INC$33.4M+70.5%+171.8%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
VRNACALLVERONA PHARMA PLC$-28.0M-89.7%
VRNACALLVERONA PHARMA PLC$-28.0M-89.7%
NBIXNEUROCRINE BIOSCIENCES INC$-65.0M-67.3%
ADMAADMA BIOLOGICS INC$-9.8M-61.7%
NTRANATERA INC$-29.5M-58.5%
SWTXSPRINGWORKS THERAPEUTICS INC$-40.1M-58.1%
BCYCBICYCLE THERAPEUTICS PLC$-5.8M-55.2%
CRNXCRINETICS PHARMACEUTICALS IN$-29.1M-50.9%
← Back to Hedge Funds